Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Healthcare Prescriptive Analytics Market

  • MAR2979350
  • 208 Pages
  • January 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Prescriptive analytics is one of the big 3s of Big Data analytics along with descriptive analytics and predictive analytics. These are interrelated solutions that can be used by companies to efficiently utilize the big data that they are currently equipped with. One of the primary tasks is to know when and where to implement which kind of analytics. While descriptive analytics talks about ‘what has happened' and predictive analytics emphasizes on ‘what can happen in the future from current patterns,' the prescriptive analysis gives a solution to ‘what should a business do to maximize its key metrics.' Thus prescriptive analytics is the stage which provides action plans on how to proceed in future based on descriptive and predictive datasets. Aurora Health Care systems saved $6million annually by applying prescriptive analytics to reduce re-admission rate by 10%. Since prescriptive analytics is comparatively complex, many organizations are yet to utilize the potential. However, large organizations are managing their day-to-day operations like scheduling inventory and optimizing production using prescriptive analytics.

Market Dynamics

Since healthcare prescriptive analytics is the next step of predictive analytics, many drivers and inhibitors are similar for both markets. The primary market driver is the need to implement efficient process regarding cost cutting and reduction of unnecessary efforts. This will ensure utilization of resources in a proper manner. Furthermore, because of integration of Big Data in healthcare, the requirement of prescriptive analysis to create action plans based on past trends will expand. Additionally, with increasing advancements in technology, need to develop prescriptive analytics will form the competitive edge and thus, because of movement towards prescriptive analytics, growth will be further enhanced. However, due to high costs associated with the initial investment required to establish prescriptive analytics system, the increase will get negatively affected. The issue of initial investment is further escalated by the costs associated with training labor to understand the nuances of technology and therefore, lack of availability of skilled IT labors acts as another inhibitor of the market growth. Apart from these factors, growing concerns about data privacy and security of the same impacts the procurement of necessary data required to generate data based solutions.

Market Segmentation

The major forms of segmentation of healthcare predictive analytics market include segmentation by component, by application, by deployment, by end-user and by geography. By component, software, hardware and services cover the entire market. By application, a market is categorized as Clinical Analysis, Financial Analysis, Operational Analysis and Research Analysis. Segmentation through deployment includes On-Premise, Web-based and Cloud-based. By end-user, segmentation comprises Physicians, Private Organizations, Hospitals, Clinics and, Government and Research Institutions. By geography, North America, Europe, Asia-Pacific and, Middle East and Africa form the entire market. Currently, Clinical Analytics segment is forecasted to have the maximum growth in application segmentation. Although Cloud-based services are gaining traction massively, yet, On-Premise solutions have captured the highest market share in deployment category.

Geographical Analysis

North America is leading the market because of the presence of giants like IBM and Oracle. Europe is following North America with second most significant market share. Asia-Pacific region is expected to grow at highest growth rate.

Key Players

The critical players in the market include IBM, Cerner, Oracle, MedeAnalytics Inc., McKesson Corporation, Optum Inc. and AllScripts Healthcare Solutions Inc.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390